ReP USP - Resultado da busca

Artigo de periodico
Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management (2017)
Mancini, G. B. John; Gupta, Milan; Tsigoulis, Michelle; Cannon, Christopher P; Genest, Jacques; Kay, Kausik K; Santos Filho, Raul Dias dos; Watts, Gerald F; Raggi, Paolo
Source: Atherosclerosis. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES, FATORES DE RISCO, LIPOPROTEÍNAS HDL, ANGINA PECTORIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANCINI, G. B. John et al. Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management. Atherosclerosis, v. 263, p. 112-118, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2017.06.006. Acesso em: 08 nov. 2024.
APA
Mancini, G. B. J., Gupta, M., Tsigoulis, M., Cannon, C. P., Genest, J., Kay, K. K., et al. (2017). Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management. Atherosclerosis, 263, 112-118. doi:10.1016/j.atherosclerosis.2017.06.006
NLM
Mancini GBJ, Gupta M, Tsigoulis M, Cannon CP, Genest J, Kay KK, Santos Filho RD dos, Watts GF, Raggi P. Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management [Internet]. Atherosclerosis. 2017 ; 263 112-118.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.006
Vancouver
Mancini GBJ, Gupta M, Tsigoulis M, Cannon CP, Genest J, Kay KK, Santos Filho RD dos, Watts GF, Raggi P. Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management [Internet]. Atherosclerosis. 2017 ; 263 112-118.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.006
Artigo de periodico
Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel (2015)
Al-Ashwal, Abdullah; Alnouri, Fahad; Sabbour, Hani; Al-Mahfouz, Abdulraof; Al-Sayed, Nasreen; Razzaghy-Azar, Maryam; Al-Allaf, Faisal; Al-Waili, Khalid; Banerjee, Yajnavalka; Genest, Jacques; Santos, Raul D.; Al-Rasadi, Khalid
Source: Current Vascular Pharmacology. Unidade: FM
Subjects: DOENÇAS GENÉTICAS, MUTAÇÃO GENÉTICA, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AL-ASHWAL, Abdullah et al. Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel. Current Vascular Pharmacology, v. 13, n. 6, p. 759-770, 2015Tradução . . Disponível em: https://doi.org/10.2174/1570161113666150827125040. Acesso em: 08 nov. 2024.
APA
Al-Ashwal, A., Alnouri, F., Sabbour, H., Al-Mahfouz, A., Al-Sayed, N., Razzaghy-Azar, M., et al. (2015). Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel. Current Vascular Pharmacology, 13( 6), 759-770. doi:10.2174/1570161113666150827125040
NLM
Al-Ashwal A, Alnouri F, Sabbour H, Al-Mahfouz A, Al-Sayed N, Razzaghy-Azar M, Al-Allaf F, Al-Waili K, Banerjee Y, Genest J, Santos RD, Al-Rasadi K. Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel [Internet]. Current Vascular Pharmacology. 2015 ; 13( 6): 759-770.[citado 2024 nov. 08 ] Available from: https://doi.org/10.2174/1570161113666150827125040
Vancouver
Al-Ashwal A, Alnouri F, Sabbour H, Al-Mahfouz A, Al-Sayed N, Razzaghy-Azar M, Al-Allaf F, Al-Waili K, Banerjee Y, Genest J, Santos RD, Al-Rasadi K. Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel [Internet]. Current Vascular Pharmacology. 2015 ; 13( 6): 759-770.[citado 2024 nov. 08 ] Available from: https://doi.org/10.2174/1570161113666150827125040
Artigo de periodico
An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report (2014)
Grundy, Scott M.; Arai, Hidenori; Barter, Philip; Bersot, Thomas P.; Betteridge, D. John; Carmena, Rafael; Cuevas, Ada; Davidson, Michael H.; Genest, Jacques; Kes€aniemi, Y. Antero; Sadikot, Shaukat; Santos, Raul D.; Susekov, Andrey V.; Sy, Rody G.; LaleTokg€ozoglu, S.; Watts, Gerald F.; Zhao, Dong
Source: Journal of clinical lipidology. Unidade: FM
Subjects: FATORES DE RISCO, MODO DE VIDA (TERAPIA), COLESTEROL, SÍNDROME X METABÓLICA, DISLIPIDEMIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRUNDY, Scott M. et al. An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report. Journal of clinical lipidology, v. 8, n. 1, p. 29-60, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.jacl.2013.12.005. Acesso em: 08 nov. 2024.
APA
Grundy, S. M., Arai, H., Barter, P., Bersot, T. P., Betteridge, D. J., Carmena, R., et al. (2014). An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report. Journal of clinical lipidology, 8( 1), 29-60. doi:10.1016/j.jacl.2013.12.005
NLM
Grundy SM, Arai H, Barter P, Bersot TP, Betteridge DJ, Carmena R, Cuevas A, Davidson MH, Genest J, Kes€aniemi YA, Sadikot S, Santos RD, Susekov AV, Sy RG, LaleTokg€ozoglu S, Watts GF, Zhao D. An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report [Internet]. Journal of clinical lipidology. 2014 ; 8( 1): 29-60.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.jacl.2013.12.005
Vancouver
Grundy SM, Arai H, Barter P, Bersot TP, Betteridge DJ, Carmena R, Cuevas A, Davidson MH, Genest J, Kes€aniemi YA, Sadikot S, Santos RD, Susekov AV, Sy RG, LaleTokg€ozoglu S, Watts GF, Zhao D. An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report [Internet]. Journal of clinical lipidology. 2014 ; 8( 1): 29-60.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.jacl.2013.12.005
Artigo de periodico
Residual macrovascular risk in 2013: what have we learned? (2014)
Fruchart, Jean-Charles; Davignon, Jean; Hermans, Michel P.; Al-Rubeaan, Khalid; Amarenco, Pierre; Assmann, Gerd; Barter, Philip; Betteridge, John; Bruckert, Eric; Cuevas, Ada; Farnier, Michel; Ferrannini, Ele; Fioretto, Paola; Genest, Jacques; Ginsberg, Henry N.; Gotto, Antonio M.; Hu, Dayi; Kadowaki, Takashi; Kodama, Tatsuhiko; Krempf, Michel; Matsuzawa, Yuji; Núñez-Cortés, Jesús; Monfil, Carlos; Ogawa, Hisao; Plutzky, Jorge; Rader, Daniel J.; Sadikot, Shaukat; Santos, Raul D.; Shlyakhto, Evgeny; Sritara, Piyamitr; Sy, Rody; Tall, Alan; Tan, Chee Eng; Tokgözoğlu, Lale; Toth, Peter P.; Valensi, Paul; Wanner, Christoph; Zambon, Alberto; Zhu, Junren; Zimmet, Paul
Source: Cardiovascular Diabetology. Unidade: FM
Subjects: FATORES DE RISCO, SISTEMA CARDIOVASCULAR (ANORMALIDADES), DISLIPIDEMIAS, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRUCHART, Jean-Charles et al. Residual macrovascular risk in 2013: what have we learned?. Cardiovascular Diabetology, v. 13, n. 26, p. 17 (on-line), 2014Tradução . . Disponível em: https://doi.org/10.1186/1475-2840-13-26. Acesso em: 08 nov. 2024.
APA
Fruchart, J. -C., Davignon, J., Hermans, M. P., Al-Rubeaan, K., Amarenco, P., Assmann, G., et al. (2014). Residual macrovascular risk in 2013: what have we learned? Cardiovascular Diabetology, 13( 26), 17 (on-line). doi:10.1186/1475-2840-13-26
NLM
Fruchart J-C, Davignon J, Hermans MP, Al-Rubeaan K, Amarenco P, Assmann G, Barter P, Betteridge J, Bruckert E, Cuevas A, Farnier M, Ferrannini E, Fioretto P, Genest J, Ginsberg HN, Gotto AM, Hu D, Kadowaki T, Kodama T, Krempf M, Matsuzawa Y, Núñez-Cortés J, Monfil C, Ogawa H, Plutzky J, Rader DJ, Sadikot S, Santos RD, Shlyakhto E, Sritara P, Sy R, Tall A, Tan CE, Tokgözoğlu L, Toth PP, Valensi P, Wanner C, Zambon A, Zhu J, Zimmet P. Residual macrovascular risk in 2013: what have we learned? [Internet]. Cardiovascular Diabetology. 2014 ; 13( 26): 17 (on-line).[citado 2024 nov. 08 ] Available from: https://doi.org/10.1186/1475-2840-13-26
Vancouver
Fruchart J-C, Davignon J, Hermans MP, Al-Rubeaan K, Amarenco P, Assmann G, Barter P, Betteridge J, Bruckert E, Cuevas A, Farnier M, Ferrannini E, Fioretto P, Genest J, Ginsberg HN, Gotto AM, Hu D, Kadowaki T, Kodama T, Krempf M, Matsuzawa Y, Núñez-Cortés J, Monfil C, Ogawa H, Plutzky J, Rader DJ, Sadikot S, Santos RD, Shlyakhto E, Sritara P, Sy R, Tall A, Tan CE, Tokgözoğlu L, Toth PP, Valensi P, Wanner C, Zambon A, Zhu J, Zimmet P. Residual macrovascular risk in 2013: what have we learned? [Internet]. Cardiovascular Diabetology. 2014 ; 13( 26): 17 (on-line).[citado 2024 nov. 08 ] Available from: https://doi.org/10.1186/1475-2840-13-26

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation

Countries of institutions of collaboration